ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 1,754.00
-29.00 (-1.63%)
At close: Sep 23, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 47.27 billion as of September 25, 2026. Its market cap has decreased by -3.99% in one year.
Market Cap
47.27B
Enterprise Value
45.48B
Revenue
12.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,754.00
ChartMarket Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 47.27B, an increase of 86.51%. That is a compound annual growth rate of 9.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 47.27B | 42.33% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psomagen | 59.92B |
| TegoScience | 57.57B |
| CHOOLIP & SCIENCES | 56.28B |
| J2KBIO | 53.91B |
| KoBioLabs | 51.75B |
| QuadMedicine | 51.04B |
| Quratis | 48.15B |
| Parataxis Korea | 44.13B |